GYRE THERAPEUTICS INC COM - Stock (CBIO)

CUSIP: 14888D208

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / Stock
Total 13F shares
7,865,370
Share change
-257,319
Total reported value
$84,773,193
Put/Call ratio
642%
Price per share
$10.78
Number of holders
67
Value change
-$4,283,725
Number of buys
41
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GYRE THERAPEUTICS INC COM - Stock (CBIO) as of Q3 2018

As of 30 Sep 2018, GYRE THERAPEUTICS INC COM - Stock (CBIO) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,865,370 shares. The largest 10 holders included NEXTHERA CAPITAL LP, BlackRock Inc., Vanguard Group Inc, Sio Capital Management, LLC, MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, GSA CAPITAL PARTNERS LLP, and FIRST MANHATTAN CO. This page lists 67 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.